Y-90 Radiation Segmentectomy for HCC

Dr. Ashwin Singh Parihar sits down with to discuss how post-therapy Lutetium 177 PSMA SPECT CT may help predict overall survival in patients with metastatic castration resistant prostate cancer and shape future treatment decisions. Drawing from the ENZAPI trial, they explore quan ...  Show more

Dr. Siddhant Dogra sits down with Dr. Su Hwan Kim to discuss how reader experience influences the performance and real world utility of large language models for brain MRI differential diagnosis. Together they explore AI assisted decision making, automation bias, radiology traini ...  Show more

BSA, MIRD, or voxel-based dosimetry? Join us for part 2 of Dosimetry University where interventional oncologists Dr. Tyler Sandow, Dr. Nima Kokabi, and Dr. Kavi Krishnasamy explore and debate the critical nuances of a successful Y90 procedure, covering dosing methods, lung shunt ...  Show more

Interview with Arjen van der Veen, MD, PhD, and Richard van Hillegersberg, MD, PhD, authors of Cost-effectiveness of Laparoscopic vs Open Gastrectomy for Gastric Cancer: An Economic Evaluation Alongside a Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: C ...  Show more

In the first part of our Hollywood tour, Amar Kishan, MD, joins us to discuss his recent meta-analysis published in the Journal of Clinical Oncology on the effects of concurrent adjuvant sequencing versus neoadjuvant concurrent sequencing. Dr. Kishan also gives an overview of ...

In this episode I cover liver cancer, particularly hepatocellular carcinoma and cholangiocarcinoma. We also touch on focal nodular hyperplasia of the liver and haemangiomas of the liver.

If you want to follow along with written notes on liver cancer go to zerotofinals ...